This observation is further supported by a higher prevalence of IgA deficiency in the GLILD+ group (Table 4), consistent with prior findings by Cinetto et al., who reported significantly lower IgG and IgA concentrations in GLILD patients compared to CVID controls (29). This evidence concerns the gene CD79A and selective IgA deficiency disease.